GAITHERSBURG, MD, September 30, 2021 – Adaptive Phage Therapeutics, Inc. (APT), a clinical-stage biotechnology…
Super UserOctober 4, 2021
Today, EDA announced that 50 organizations — including nonprofits, institutions of higher…
Super UserOctober 4, 2021
Barbara Schilberg retiring as Managing Director and CEO;Shahram Hejazi, Ph.D., appointed as…
Super UserOctober 4, 2021
September 28, 2021 RESTON, Virginia—During a year of unprecedented reliance on intellectual…
Super UserSeptember 29, 2021
GAITHERSBURG, Md., Sept. 28, 2021 /PRNewswire/ -- Cartesian Therapeutics, a fully integrated, clinical-stage…
Super UserSeptember 29, 2021
Universities have long nurtured the development of new ideas. Over the last…
Super UserSeptember 29, 2021
BARDA's Division of Research, Innovation, and Ventures (DRIVe) and the National Center for…
Super UserSeptember 29, 2021